Abstract
Thioetherhydroxyethylsulfonamide derivatives were synthesized and evaluated for their in vitro antibacterial activity against Escherichia coli (ATCC 25922), Pseudomonas aeruginosa (ATCC 27853) and Staphylococcus aureus (ATCC 25923). Results have shown that compounds 8c and 9e display potent activity (MIC = 0.125 µg/mL) against E. coli when compared with the standard drug sulfamethoxazole (SMZ, MIC < 0.5 µg/mL) for this same strain. All the new compounds were fully identified and characterized by NMR (1H and 13C) and X-ray crystallography (for compound 8c). This class of compounds can be considered as a good starting point for the development of new lead molecules in the fight against multi-drug bacterial resistance.
Keywords: Antibacterial, chemical biology, drugs, sulfonamides, thioetherhydroxyethylsulfonamides, X-Ray.
Medicinal Chemistry
Title:Antibacterial Activity of Thioetherhydroxyethylsulfonamide Derivatives
Volume: 10 Issue: 3
Author(s): Walcimar T. Vellasco Junior, Guilherme P. Guedes, Victor Facchinetti, Thatyana R.A. Vasconcelos, Maria G.F. Vaz, Wilson Cunico, Marcus V.N. de Souza, Geraldo R. de Paula, Maria E.C.K. Fleming and Claudia R.B. Gomes
Affiliation:
Keywords: Antibacterial, chemical biology, drugs, sulfonamides, thioetherhydroxyethylsulfonamides, X-Ray.
Abstract: Thioetherhydroxyethylsulfonamide derivatives were synthesized and evaluated for their in vitro antibacterial activity against Escherichia coli (ATCC 25922), Pseudomonas aeruginosa (ATCC 27853) and Staphylococcus aureus (ATCC 25923). Results have shown that compounds 8c and 9e display potent activity (MIC = 0.125 µg/mL) against E. coli when compared with the standard drug sulfamethoxazole (SMZ, MIC < 0.5 µg/mL) for this same strain. All the new compounds were fully identified and characterized by NMR (1H and 13C) and X-ray crystallography (for compound 8c). This class of compounds can be considered as a good starting point for the development of new lead molecules in the fight against multi-drug bacterial resistance.
Export Options
About this article
Cite this article as:
Vellasco Junior T. Walcimar, Guedes P. Guilherme, Facchinetti Victor, Vasconcelos R.A. Thatyana, Vaz G.F. Maria, Cunico Wilson, de Souza V.N. Marcus, de Paula R. Geraldo, Fleming E.C.K. Maria and Gomes R.B. Claudia, Antibacterial Activity of Thioetherhydroxyethylsulfonamide Derivatives, Medicinal Chemistry 2014; 10 (3) . https://dx.doi.org/10.2174/1573406410666140218103022
DOI https://dx.doi.org/10.2174/1573406410666140218103022 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Is there U-turn from Insulin Back to Pills in Diabetes?
Current Vascular Pharmacology Hepatic AMP Kinase as a Potential Target for Treating Nonalcoholic Fatty Liver Disease: Evidence from Studies of Natural Products
Current Medicinal Chemistry Synthesis, In Vitro Activities of (2-Cyclopropoxyphenyl)piperidine Derivatives for α1a and α1d Adrenergic Receptor Inhibitors
Medicinal Chemistry Mas Receptor Agonists as Novel Antihypertensive Agents
Current Hypertension Reviews Therapeutic Antibodies and Other Proteins Obtained by Molecular Display Technologies
Recent Patents on Biotechnology All-trans Retinoic Acid Increased Transglutaminase 2 Expressions in BV-2 Cells and Cultured Astrocytes
Current Molecular Pharmacology Transient Elastography in HIV Infected Patients with Liver Steatosis Identifies a High-Risk Group for Non-Alcoholic Steatohepatitis
Current HIV Research Circulating Insulin-like Growth Factor-1 Levels in Patients with Rheumatoid Arthritis: A Meta-analysis
Current Pharmaceutical Design Progress and Prospects in Translating Nanobiotechnology in Medical Theranostics
Current Nanoscience The Development of New Nonenzymatic Glucose Biosensors Using Nanomaterials
Current Nanoscience Fatty Acids and Obesity
Current Pharmaceutical Design Overcoming the Hurdles of Tumor Immunity by Targeting Regulatory Pathways in Innate and Adaptive Immune Cells
Current Pharmaceutical Design cGMP Signaling, Phosphodiesterases and Major Depressive Disorder
Current Neuropharmacology Sports Medicine Applications of Platelet Rich Plasma
Current Pharmaceutical Biotechnology Progression of Retinopathy in Type 1 Diabetic Women During Pregnancy
Current Diabetes Reviews Genetic Polymorphisms of Cytochrome p450 (2C9) Enzyme in Patients with Type 2 Diabetes Mellitus in Turkmen and Fars Ethnic Groups
Endocrine, Metabolic & Immune Disorders - Drug Targets Therapeutic Strategies to Target TGF-β in the Treatment of Bone Metastases
Current Pharmaceutical Biotechnology Enhanced Tolerance against Early and Late Apoptotic Oxidative Stress in Mammalian Neurons through Nicotinamidase and Sirtuin Mediated Pathways
Current Neurovascular Research Getting Rid of Intracellular Aβ - Loss of Cellular Degradation Leads to Transfer Between Connected Neurons
Current Pharmaceutical Design Cannabinoids and Cardiovascular Disease: The Outlook for Clinical Treatments
Current Vascular Pharmacology